W A Gattis

Summary

Affiliation: Duke University Medical Center
Country: USA

Publications

  1. ncbi request reprint Reduction in heart failure events by the addition of a clinical pharmacist to the heart failure management team: results of the Pharmacist in Heart Failure Assessment Recommendation and Monitoring (PHARM) Study
    W A Gattis
    Department of Medicine, Duke University Medical Center, Durham, NC 27710, USA
    Arch Intern Med 159:1939-45. 1999
  2. ncbi request reprint Continuous intravenous dobutamine is associated with an increased risk of death in patients with advanced heart failure: insights from the Flolan International Randomized Survival Trial (FIRST)
    C M O'Connor
    Duke University Medical Center, Durham, NC 27710, USA
    Am Heart J 138:78-86. 1999
  3. ncbi request reprint Clinical characteristics and long-term outcomes of patients with heart failure and preserved systolic function
    C M O'Connor
    Duke University Medical Center and Duke Clinical Research Institute, Durham, North Carolina, USA
    Am J Cardiol 86:863-7. 2000
  4. ncbi request reprint The benefit of implementing a heart failure disease management program
    D J Whellan
    Division of Cardiology, Department of Medicine, Box 3356, Duke University Medical Center, Durham, NC 27710, USA
    Arch Intern Med 161:2223-8. 2001
  5. ncbi request reprint Comparison of two aspirin doses on ischemic stroke in post-myocardial infarction patients in the warfarin (Coumadin) Aspirin Reinfarction Study (CARS)
    C M O'Connor
    Department of Medicine, Duke Clinical Research Institute, Duke University Medical Center, Durham, North Carolina 27710, USA
    Am J Cardiol 88:541-6. 2001

Collaborators

Detail Information

Publications5

  1. ncbi request reprint Reduction in heart failure events by the addition of a clinical pharmacist to the heart failure management team: results of the Pharmacist in Heart Failure Assessment Recommendation and Monitoring (PHARM) Study
    W A Gattis
    Department of Medicine, Duke University Medical Center, Durham, NC 27710, USA
    Arch Intern Med 159:1939-45. 1999
    ..The multidisciplinary approach to managing heart failure has been shown to improve outcomes. The role of a clinical pharmacist in treating heart failure has not been evaluated...
  2. ncbi request reprint Continuous intravenous dobutamine is associated with an increased risk of death in patients with advanced heart failure: insights from the Flolan International Randomized Survival Trial (FIRST)
    C M O'Connor
    Duke University Medical Center, Durham, NC 27710, USA
    Am Heart J 138:78-86. 1999
    ..To evaluate clinical characteristics and outcomes of patients with advanced heart failure receiving intravenous continuous dobutamine in the FIRST Trial (Flolan International Randomized Survival Trial)...
  3. ncbi request reprint Clinical characteristics and long-term outcomes of patients with heart failure and preserved systolic function
    C M O'Connor
    Duke University Medical Center and Duke Clinical Research Institute, Durham, North Carolina, USA
    Am J Cardiol 86:863-7. 2000
    ..Furthermore, several clinical and angiographic characteristics are predictive of long-term survival...
  4. ncbi request reprint The benefit of implementing a heart failure disease management program
    D J Whellan
    Division of Cardiology, Department of Medicine, Box 3356, Duke University Medical Center, Durham, NC 27710, USA
    Arch Intern Med 161:2223-8. 2001
    ..We undertook this study to evaluate the potential benefit of implementing a CHF disease management program at a tertiary care center, particularly in terms of beta-blocker use and cost to the health care system...
  5. ncbi request reprint Comparison of two aspirin doses on ischemic stroke in post-myocardial infarction patients in the warfarin (Coumadin) Aspirin Reinfarction Study (CARS)
    C M O'Connor
    Department of Medicine, Duke Clinical Research Institute, Duke University Medical Center, Durham, North Carolina 27710, USA
    Am J Cardiol 88:541-6. 2001
    ..The results of this secondary analysis suggest that aspirin 160 mg is more effective than aspirin 80 mg + warfarin 1 mg in preventing ischemic stroke in post-myocardial infarction patients...